Photo by adeolueletu from unsplash
Numerous experimental and targeted therapies are under investigation for patients with cholangiocarcinoma (CCA). Objective health‐related quality of life (HRQoL) data for patients receiving these therapies are limited. Click to show full abstract
Numerous experimental and targeted therapies are under investigation for patients with cholangiocarcinoma (CCA). Objective health‐related quality of life (HRQoL) data for patients receiving these therapies are limited.
Keywords:
reported outcomes;
patient reported;
financial toxicity;
toxicity barrier;
barrier clinical;
outcomes financial
Journal Title: Journal of Surgical Oncology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Surgical Oncology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!